|
1
|
Zhuang L, Jin G, Hu X, Yang Q and Shi Z:
The inhibition of SGK1 suppresses epithelial-mesenchymal transition
and promotes renal tubular epithelial cell autophagy in diabetic
nephropathy. Am J Transl Res. 11:4946–4956. 2019.PubMed/NCBI
|
|
2
|
Coskun ZM, Ersoz M, Adas M, Hancer VS,
Boysan SN, Gonen MS and Acar A: Kruppel-like transcription factor-4
gene expression and DNA methylation status in type 2 diabetes and
diabetic nephropathy patients. Arch Med Res. 50:91–97.
2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Jiang S, Yu T, Zhang Z, Fang J, Wang Y,
Yang Y, Liu L, Zou G, Gao H, Zhuo L, et al: Prognostic nomogram and
score to predict renal survival of patients with biopsy-proven
diabetic nephropathy. Diabetes Res Clin Pract.
155(107809)2019.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Grujicic M, Salapura A, Basta-Jovanovic G,
Figurek A, Micic-Zrnic D and Grbic A: Non-diabetic kidney disease
in patients with type 2 diabetes mellitus - 11-year experience from
a single center. Med Arh. 73:87–91. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Fawzy MS and Beladi FI: Association of
circulating vitamin D, VDBP, and vitamin D receptor expression with
severity of diabetic nephropathy in a group of Saudi type 2
diabetes mellitus patients. Clin Lab. 64:1623–1633. 2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mirković K, Doorenbos CR, Dam WA, Lambers
Heerspink HJ, Slagman MC, Nauta FL, Kramer AB, Gansevoort RT, van
den Born J, Navis G, et al: Urinary vitamin D binding protein: A
potential novel marker of renal interstitial inflammation and
fibrosis. PLoS One. 8(e55887)2013.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Gu J, Huang W, Zhang W, Zhao T, Gao C, Gan
W, Rao M, Chen Q, Guo M, Xu Y, et al: Sodium butyrate alleviates
high-glucose -induced renal glomerular endothelial cells damage via
inhibiting pyroptosis. Int Immunopharmacol.
75(105832)2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Ebadi Z, Moradi N, Kazemi Fard T,
Balochnejadmojarrad T, Chamani E, Fadaei R and Fallah S: Captopril
and spironolactone can attenuate diabetic nephropathy in Wistar
rats by targeting microRNA-192 and microRNA-29a/b/c. DNA Cell Biol.
38:1134–1142. 2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Shi Q, Zhang Y, Liu W, Xiao H, Qi Y, Li J
and Luo B: Latent membrane protein 2A inhibits expression level of
Smad2 through regulating miR-155-5p in EBV-associated gastric
cancer cell lines. J Med Virol. 92:96–106. 2020.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Wang J, Wang G, Liang Y and Zhou X:
Expression profiling and clinical significance of plasma microRNAs
in diabetic nephropathy. J Diabetes Res.
2019(5204394)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Xie J, Wang X, Zhang Y, Li H, Xu Y and
Zheng D: The longitudinal effect of subclinical hypothyroidism on
urine microalbumin-to-urine creatinine ratio in patients with type
2 diabetes mellitus. BMC Endocr Disord. 19(84)2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Krueger DA, Northrup H, Northrup H,
Krueger DA, Roberds S, Smith K, Sampson J, Korf B, Kwiatkowski DJ,
Mowat D, et al: International Tuberous Sclerosis Complex Consensus
Group: Tuberous sclerosis complex surveillance and management:
Recommendations of the 2012 International Tuberous Sclerosis
Complex Consensus Conference. Pediatr Neurol. 49:255–265.
2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Kocak MZ, Aktas G, Erkus E, Duman TT, Atak
BM and Savli H: Mean platelet volume to lymphocyte ratio as a novel
marker for diabetic nephropathy. J Coll Physicians Surg Pak.
28:844–847. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Prabu P, Rome S, Sathishkumar C, Gastebois
C, Meugnier E, Mohan V and Balasubramanyam M: MicroRNAs from
urinary extracellular vesicles are non-invasive early biomarkers of
diabetic nephropathy in type 2 diabetes patients with the ‘Asian
Indian phenotype’. Diabetes Metab. 45:276–285. 2019.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Fawzy MS and Abu AlSel BT: Assessment of
vitamin D-binding protein and early prediction of nephropathy in
type 2 Saudi diabetic patients. J Diabetes Res.
2018(8517929)2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Shoukry A, Bdeer S-A and El-Sokkary RH:
Urinary monocyte chemoattractant protein-1 and vitamin D-binding
protein as biomarkers for early detection of diabetic nephropathy
in type 2 diabetes mellitus. Mol Cell Biochem. 408:25–35.
2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tian XQ, Zhao LM, Ge JP, Zhang Y and Xu
YC: Elevated urinary level of vitamin D-binding protein as a novel
biomarker for diabetic nephropathy. Exp Ther Med. 7:411–416.
2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Akhbari M, Khalili M, Shahrabi-Farahani M,
Biglari A and Bandarian F: Expression level of circulating cell
free miR-155 gene in serum of patients with diabetic nephropathy.
Clin Lab. 65(65)2019.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L,
Weng J and Yu Z: Curcumin attenuates urinary excretion of albumin
in type II diabetic patients with enhancing nuclear factor
erythroid-derived 2-like 2 (Nrf2) system and repressing
inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes.
123:360–367. 2015.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Siddiqi Z, Karoli R, Kaul A, Fatima J,
Varshney S and Beg MS: Evaluation of neutrophil
gelatinase-associated lipocalin and cystatin C as early markers of
diabetic nephropathy. Ann Afr Med. 16:101–106. 2017.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liu R, Zhu H, Yang JH, Gao ZA, Yuan XX, Li
XC, Wang JY and Chang BC: Can urine albumin/creatinine ratio
replace 24 hs urinary albumin? Zhonghua Nei Ke Za Zhi. 58:377–381.
2019.PubMed/NCBI View Article : Google Scholar : (In Chinese).
|
|
22
|
Huang Y, Liu Y, Li L, Su B, Yang L, Fan W,
Yin Q, Chen L, Cui T, Zhang J, et al: Involvement of
inflammation-related miR-155 and miR-146a in diabetic nephropathy:
Implications for glomerular endothelial injury. BMC Nephrol.
15(142)2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Wang G, Ouyang J, Li S, Wang H, Lian B,
Liu Z and Xie L: The analysis of risk factors for diabetic
nephropathy progression and the construction of a prognostic
database for chronic kidney diseases. J Transl Med.
17(264)2019.PubMed/NCBI View Article : Google Scholar
|
